Genome-wide Analysis of Myelodysplastic Syndromes

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|18|22|3163-3169

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.18, Iss.22, 2012-07, pp. : 3163-3169

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Significance of Genome-Wide Analysis of Copy Number Alterations and UPD in Myelodysplastic Syndromes using Combined CGH – SNP Arrays

By  

Current Medicinal Chemistry, Vol. 19, Iss. 22, 2012-08 ,pp. : 3739-3747

Bentham Science Publishers

Access to resources Recommend Favorite

Meta-analysis in genome-wide association studies

By Zeggini Eleftheria   Ioannidis John PA  

Pharmacogenomics, Vol. 10, Iss. 2, 2009-02 ,pp. : 191-201

Future Medicine

Access to resources Recommend Favorite

Genome-Wide Expression Analysis in Epilepsy: A Synthetic Review

By  

Current Topics in Medicinal Chemistry, Vol. 12, Iss. 9, 2012-05 ,pp. : 1008-1032

Bentham Science Publishers

Access to resources Recommend Favorite

Myelodysplastic Syndromes

By  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 6, Iss. 9, 2008-10 ,pp. : 902-902

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Editorial: [Hot Topic: Genome-Wide Analysis of Drug Action]

By Sharma Abhay  

Current Psychopharmacology, Vol. 1, Iss. 4, 2012-11 ,pp. : 271-271

Bentham Science Publishers

Access to resources Recommend Favorite